PEDIATRICS Vol. 99 No. 4 April 1997, pp. 555-559 (doi:10.1542/peds.99.4.555)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mirochnick, M.
Right arrow Articles by Zuckerman, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mirochnick, M.
Right arrow Articles by Zuckerman, B.
Related Collections
Right arrow Therapeutics & Toxicology

PEDIATRICS Vol. 99 No. 4 April 1997, pp. 555-559

Elevated Plasma Norepinephrine After In Utero Exposure to Cocaine and Marijuana

Received Feb 8, 1996; accepted Aug 16, 1996.

Mark Mirochnick*, Jerrold Meyer§, Deborah A. Frank*, Howard CabralDagger , Edward Z. Tronickparallel , and Barry Zuckerman*

From the * Department of Pediatrics, Boston City Hospital and Boston University School of Medicine, and the Dagger  Boston University School of Public Health, Boston, Massachusetts; the § Department of Psychology, Neuroscience and Behavior Program, University of Massachusetts at Amherst, Amherst, Massachusetts; and the parallel  Child Development Unit, Children's Hospital, Harvard Medical School, Boston, Massachusetts

Objective.  To compare plasma catecholamine concentrations between cocaine-exposed and unexposed term newborns and to determine the relationship between plasma catecholamines and newborn behavior.

Methods.  Forty-six newborn infants participating in a prospective study of the neonatal and long-term effects of prenatal cocaine exposure were studied. Based on maternal self-report, maternal urine screening, and infant meconium analysis, 24 infants were classified as cocaine-exposed and 22 as unexposed. Between 24 and 72 hours postpartum, plasma samples for norepinephrine (NE), epinephrine, dopamine, and dihydroxyphenylalanine analysis were obtained. The Neonatal Behavioral Assessment Scale was administered at 1 to 3 days of age and at 2 weeks of age by examiners masked to the drug exposure status of the newborns.

Results.  The cocaine-exposed newborns had increased plasma NE concentrations when compared to the unexposed infants (geometric mean, 923 pg/mL vs 667 pg/mL). There were no significant differences in plasma epinephrine, dopamine, or dihydroxyphenylalanine concentrations. Analysis for the effect of potential confounding variables revealed that maternal marijuana use was also associated with increased plasma NE, although birth weight, gender, and maternal use of alcohol or cigarettes were not. Geometric mean plasma NE was 1164 pg/mL in those infants with in utero exposure to both cocaine and marijuana compared to 812 pg/mL in those exposed to only cocaine and 667 pg/mL in those exposed to neither. Among the cocaine-exposed infants, plasma NE concentration correlated with an increased score for the depressed cluster (r = .53) and a decreased score for the orientation cluster (r = -.43) of the Neonatal Behavioral Assessment Scale administered at 1 to 3 days of age. Adjusting for marijuana exposure had no effect on these relationships between plasma NE and the depressed and orientation clusters.

Conclusion.  Plasma NE is increased in newborns exposed to cocaine and marijuana. Increased plasma NE is associated with selected neurobehavioral disturbances among cocaine exposed infants at 1 to 3 days of life but not at 2 weeks.

Key words: cocaine, catecholamines, neonate, behavior.




This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
L. S. Sun, S. Takuma, R. Lui, and S. Homma
The Effect of Maternal Cocaine Exposure on Neonatal Rat Cardiac Function
Anesth. Analg., September 1, 2003; 97(3): 878 - 882.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
V. Delaney-Black, C. Covington, T. Templin, J. Ager, B. Nordstrom-Klee, S. Martier, L. Leddick, R. H. Czerwinski, and R. J. Sokol
Teacher-Assessed Behavior of Children Prenatally Exposed to Cocaine
Pediatrics, October 1, 2000; 106(4): 782 - 791.
[Abstract] [Full Text]

Home page
 CLIN PEDIATRHome page
R. Needlman, D. A. Frank, H. Cabral, M. Mirochnick, C. Kwon, and B. Zuckerman
Blood Pressure in Children Exposed Prenatally to Cocaine
Clinical Pediatrics, November 1, 1998; 37(11): 659 - 664.
[Abstract] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
M.-C. NASSOGNE, P. EVRARD, and P. J. COURTOY
Selective Direct Toxicity of Cocaine on Fetal Mouse Neurons: Teratogenic Implications of Neurite and Apoptotic Neuronal Loss
Ann. N.Y. Acad. Sci., June 21, 1998; 846(1): 51 - 68.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
M. G. REGALADO, V. L. SCHECHTMAN, M. C.K. KHOO, J. SHIN, and X. D. BEANE
Sources of Heart Rate Variation during Sleep in Cocaine-Exposed Neonates
Ann. N.Y. Acad. Sci., June 21, 1998; 846(1): 415 - 418.
[Full Text] [PDF]